Literature DB >> 14561996

Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis.

H J Dornbusch1, V Strenger, R Kerbl, H Lackner, W Schwinger, P Sovinz, C Urban.   

Abstract

Treatment with antibodies against T-lymphocytes usually triggers a febrile response potentially mimicking or masking infection. Procalcitonin (PCT) is considered a sensitive and specific marker of systemic bacterial and fungal infection. It was the aim of this study to investigate the characteristics of PCT and C-reactive protein (CRP) during treatment with polyclonal or monoclonal anti-T-cell antibodies, in order to examine the ability of these parameters to distinguish between systemic bacterial infection and reaction to antibody treatment. Thus, 15 consecutive febrile episodes after T-cell antibody infusion without clinical signs of infection were compared with nine episodes of Gram-negative sepsis. After T-cell antibody infusion PCT and CRP serum levels increased to a similar extent as in Gram-negative sepsis. Therefore, during T-cell antibody treatment neither PCT nor CRP are adequate for differentiating between fever due to infection or to unspecific cytokine release.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561996     DOI: 10.1038/sj.bmt.1704265

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

1.  Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery.

Authors:  Christian P Schneider; Martin K Angele; Wolfgang H Hartl
Journal:  Crit Care       Date:  2010-01-21       Impact factor: 9.097

2.  Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders.

Authors:  Hans Jürgen Dornbusch; Volker Strenger; Petra Sovinz; Herwig Lackner; Wolfgang Schwinger; Reinhold Kerbl; Christian Urban
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

3.  Chemotherapy-related fever or infection fever?

Authors:  Nilgun Eroglu; Erol Erduran; Gokce Pinar Reis; Aysenur Bahadır
Journal:  Support Care Cancer       Date:  2020-08-12       Impact factor: 3.603

4.  Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid.

Authors:  Tobias Weissenbacher; Rüdiger P Laubender; Steven S Witkin; Andrea Gingelmaier; Barbara Schiessl; Franziskus Kainer; Klaus Friese; Udo Jeschke; Darius Dian; Katrin Karl
Journal:  BMC Res Notes       Date:  2012-07-24

5.  Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.

Authors:  Helena Brodska; Tomas Drabek; Karin Malickova; Antonin Kazda; Antonin Vitek; Tomas Zima; Marketa Markova
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

Review 6.  Role of Biomarkers as Predictors of Infection and Death in Neutropenic Febrile Patients after Hematopoietic Stem Cell Transplantation.

Authors:  Karin Massaro; Silvia Figueiredo Costa
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-15       Impact factor: 2.576

7.  Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.

Authors:  Katja Thomas; Judith Eisele; Francisco Alejandro Rodriguez-Leal; Undine Hainke; Tjalf Ziemssen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-04-29

8.  Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents-a single centre experience of 20 years.

Authors:  Volker Strenger; Gerald Merth; Herwig Lackner; Stephan W Aberle; Harald H Kessler; Markus G Seidel; Wolfgang Schwinger; Daniela Sperl; Petra Sovinz; Anna Karastaneva; Martin Benesch; Christian Urban
Journal:  Ann Hematol       Date:  2018-02-06       Impact factor: 3.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.